|
If your email program has trouble displaying this email, view as a webpage.
February 17, 2022
The Stakeholder Engagement Staff is pleased to announce the swearing in of Dr. Robert Califf this afternoon, Thursday, February 17, 2022
 "It is my great honor to have the opportunity to return to the FDA in the position of Commissioner. I thank President Biden for having the confidence to nominate me to lead this essential agency at such a critical time. And I want to thank the Senate for confirming me after a thorough vetting.
I am grateful to the many people at the FDA, HHS, and the White House who spent countless hours getting me through the exhaustive process. I especially want to recognize & thank Dr. Janet Woodcock, who has so ably filled the position of Acting Commissioner for more than a year. I can’t think of anyone who more capably could have handled the unprecedented challenges & extraordinary pressures that come with this position.
I am grateful that Dr. Woodcock has agreed to stay on in the position of Principal Deputy Commissioner, and I look forward to her support and advice, particularly during this critical transition period. We face enormous challenges as a nation and as an agency, and with her support and the many old and new friends at the agency, I look forward to being able to hit the ground running.
I promise each member of the FDA team and the American people my commitment to doing the best I can, relying on the integrity of science and the FDA’s continued application of science in meeting our awe-inspiring responsibilities,” said FDA’s Commissioner, Dr. Robert Califf.
|
